plicamycin has been researched along with chromomycins in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ginsburg, H; Krugliak, M; Nissani, E; Williamson, DH | 1 |
| Garcia-Ferrer, I; Mansilla, S; Méndez, C; Portugal, J; Salas, JA | 1 |
2 other study(ies) available for plicamycin and chromomycins
| Article | Year |
|---|---|
Selective toxicity to malaria parasites by non-intercalating DNA-binding ligands.
Topics: Animals; Base Composition; Bisbenzimidazole; Cell Division; Cells, Cultured; Chromomycins; Distamycins; DNA, Protozoan; Dose-Response Relationship, Drug; Humans; Indoles; Intercalating Agents; Mice; Netropsin; Nucleic Acid Conformation; Plasmodium falciparum; Plicamycin; Saccharomyces cerevisiae | 1993 |
Differential inhibition of restriction enzyme cleavage by chromophore-modified analogues of the antitumour antibiotics mithramycin and chromomycin reveals structure-activity relationships.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Chromomycin A3; Chromomycins; Colonic Neoplasms; Deoxyribonucleases, Type II Site-Specific; DNA Restriction Enzymes; Female; Flow Cytometry; Humans; Male; Ovarian Neoplasms; Plicamycin; Prostatic Neoplasms; Structure-Activity Relationship | 2010 |